Tag: WHO

WHO Made New Recommendations on Expansion of HIV Treatment Coverage

The World Health Organization (WHO) has issued new recommendations to help countries reach 8.1 million people living with HIV who are yet to be diagnosed, and who are therefore unable to obtain li...

WHO Praised Russian Stance on Proposed Heritable Human Genome Editing

gene therapy
Following the birth of the world’s first genome-edited babies in November 2018, the World Health Organization’s (WHO) Expert Advisory Committee on Human Genome Editing was established a month later to...

WHO Urges Countries to Invest at Least 1% More of GDP on Primary Health Care

Countries must increase spending on primary healthcare by at least 1% of their gross domestic product (GDP) if the world is to close glaring coverage gaps and meet health targets agreed in 2015, says ...

IAOCR to Launch New Safety Campaign

The International Academy of Clinical Research (IAOCR) has launched a new patient safety campaign, just in time for the first ever World Patient Safety Day. The campaign calls on the industry to pr...

Kenya to Use World’s First Malaria Vaccine

vaccine
Kenya has become the third African country to introduce the world’s first malaria vaccine into the country, in a phased pilot programme. The World Health Organization (WHO) has announced that Kenya...

WHO Partners with Facebook to Stop Spreading Anti-Vaccination Content

vaccine
The World Health Organization is partnering with Facebook to stop the spread of inaccurate information about vaccines, which the WHO calls “a major threat to global health that could reverse decades o...

WHO Urged Countries to Eliminate Cervical Cancer by 2030

who
World Health Organization urged countries in its South-East Asia Region to accelerate efforts to eliminate cervical cancer by 2030. “Countries need to expand vaccination, screening, detection and tre...

WHO Calls on Countries to Scale Up Investments in Eliminating Hepatitis

who
Ahead of World Hepatitis Day (28 July), WHO calls on countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease el...

WHO Revised Guidance on QMS for National GMP Inspectorates

The World Health Organization (WHO) has revised its guidance on quality system requirements for national good manufacturing practice (GMP) inspectorates to align with international standards and the l...

WHO Recommended Use of Dolutegravir as Preferred HIV Treatment Option

Based on new evidence assessing benefits and risks, the WHO recommends the use of the HIV drug dolutegravir (DTG) as the preferred first-line and second-line treatment for all populations, including p...

Global Guidance on Medicines and Diagnostic Tests Updated by WHO

WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable thro...

WHO Updated Lists of Essential Medicines and Diagnostics

who
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable thro...

Cholera Vaccination Campaign Continues in the DR Congo

Phase 2 of the biggest ever oral vaccination campaign against cholera is scheduled to take place from 3-8 July 2019 in 15 health districts in the four central provinces of the Democratic Republic of t...

Some Valsartan Versions May Contain New Cancer-Causing Impurity

Online pharmacy Valisure reported that it found a new cancer-causing impurity in some versions of widely prescribed blood pressure medicine valsartan, but U.S. regulators said on Tuesday that the amou...

WHO Urges to Use New Antimicrobial Resistance Tool

who
WHO launched a global campaign urging governments to adopt a tool to reduce the spread of antimicrobial resistance, adverse events and costs. The AWaRe tool was developed by the WHO Essential Medic...

Measures for Lowering Medicine Prices in Russia Showed to Be Effective

In 2010, Professor Liliya Ziganshina (Head of Cochrane Russia), one of the co-authors of the paper, partook in a study on access to medicines with expert advice and methodology support from the World ...